Northann Corp. (NCL): Nasdaq/NYSE listing notice — Northann Corp. receives NYSE American delisting notice for late 10-K filing

Northann Corp.

Received delisting notice from NYSE American on April 16, 2025 for failing to file Form 10-K for FY2024 by April 15 deadline.
Cure period is six months from notice date to file the 10-K; failure may lead to suspension and delisting.
Company intends to file the 10-K as soon as practicable and expects to regain compliance.
Delinquent Report due to need for more time to complete financial statement review; reference to late filing on Form 12b-25 filed March 31.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Northann Corp. received a nyse_american deficiency notice notice regarding late filing (rules 134, 1101, 1007).

Exchange: nyse american
Notice: deficiency notice
Deficiency: late filing
Rules: 134, 1101, 1007

Exact text from the filing

ions 134 and 1101 of the NYSE American Company Guide due to its delayed filings of the Form 10-K for the year ended December 31, 2024 (the “Delinquent Report”) by the filing due date of April 15, 2025 (the “Filing Delinquency”). Reference is made to the Company’s Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2025), which described the circumstances leading to the late filing of the Delinquent Report. Although the Company has dedicated significant resources to the completion of finalizing its consolidated financial statements and related disclosures for inclusion i

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Northann Corp. filing history →

Source: SEC EDGAR

accession 0001575872-25-000302

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.